Romy van Weelderen

6PUBLICATIONS
27CO-AUTHORS
Haematological tumoursInfant and child healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Romy E van Weelderen, Christine J Harrison, Kim Klein

|Jun 22, 2023
Treatment outcomes of pediatric acute myeloid leukemia in Western Kenya before and after the implementation of the SIOP PODC treatment guideline.

Romy E van Weelderen, Noa E Wijnen, Festus Njuguna

|Mar 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.

Romy E van Weelderen, Kim Klein, Christine J Harrison

|Jul 09, 2022
Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study.

Romy E Van Weelderen, Kim Klein, Bianca F Goemans

|Nov 23, 2021
Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya.

Romy E van Weelderen, Festus Njuguna, Kim Klein

|Sep 17, 2021
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study.

Kim Klein, H Berna Beverloo, Martin Zimmermann

Pageof 1

Frequent Collaborators

4 joint publications

Kim Klein

3 joint publications

Bianca F Goemans

3 joint publications

Gertjan J L Kaspers

2 joint publications

Mareike Rasche